These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA. Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [Abstract] [Full Text] [Related]
5. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis. Marras TK, Nopmaneejumruslers C, Chan CK. Am J Med; 2004 Mar 15; 116(6):385-93. PubMed ID: 15006587 [Abstract] [Full Text] [Related]
7. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W. Curr Med Res Opin; 2008 Mar 15; 24(3):895-906. PubMed ID: 18419876 [Abstract] [Full Text] [Related]
15. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia. Serisier DJ, Bowler SD. Respirology; 2007 May 15; 12(3):389-93. PubMed ID: 17539843 [Abstract] [Full Text] [Related]